Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ironwood Pharmaceuticals

0.7197
-0.0723-9.13%
Volume:1.59M
Turnover:1.17M
Market Cap:116.46M
PE:130.12
High:0.7955
Open:0.7730
Low:0.7005
Close:0.7920
Loading ...

Ironwood Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Ironwood Pharmaceuticals Q1 Adj. EPS $(0.14) Misses $(0.05) Estimate, Sales $41.14M Miss $45.98M Estimate

Benzinga
·
07 May

BRIEF-Ironwood Pharmaceuticals Q1 Revenue USD 41.143 Million Vs. IBES Estimate USD 46 Million

Reuters
·
07 May

Ironwood Pharmaceuticals Inc: Qtrly Adj Shr Loss $0.14

THOMSON REUTERS
·
07 May

Ironwood Pharmaceuticals Q1 Adjusted Ebitda USD -4.742 Million

THOMSON REUTERS
·
07 May

Ironwood Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
05 May

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Business Wire
·
01 May

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ironwood Pharma (IRWD), AbbVie (ABBV) and Molecular Partners (MOLN)

TIPRANKS
·
29 Apr

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Ironwood Pharma (IRWD) and Repligen (RGEN)

TIPRANKS
·
25 Apr

Ironwood Pharmaceuticals Inc - Raises 2025 Adjusted Ebitda Guidance to Over $105 Million

THOMSON REUTERS
·
25 Apr

Ironwood Pharmaceuticals: Do Not Plan to Make Some Apraglutide Commercial Launch Planning Investments

THOMSON REUTERS
·
25 Apr

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

Business Wire
·
25 Apr

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Business Wire
·
23 Apr

Ironwood Shares Tank on Regulatory Update for Apraglutide

Zacks
·
15 Apr

Ironwood Pharmaceuticals Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
15 Apr

Wells Fargo Downgrades Ironwood Pharmaceuticals to Equalweight From Overweight, Adjusts Price Target to $1 From $7

MT Newswires Live
·
15 Apr

U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group

Reuters
·
15 Apr

Wells downgrades Ironwood to Equal Weight on ‘major setback’

TIPRANKS
·
15 Apr

Ironwood Pharmaceuticals Is Maintained at Market Perform by Leerink Partners

Dow Jones
·
15 Apr

Top Midday Decliners

MT Newswires Live
·
15 Apr